Search Results
Search for other papers by Soo Yeon Jang in
Google Scholar
PubMed
Search for other papers by Kyung Mook Choi in
Google Scholar
PubMed
both muscles and bones. Osteosarcopenia has recently been proposed as a geriatric syndrome, indicating the presence of both osteoporosis and sarcopenia ( Hirschfeld et al. 2017 ). Signal crosstalk between muscle and bone may provoke the pathogenesis
Search for other papers by M Karin in
Google Scholar
PubMed
Search for other papers by L Chang in
Google Scholar
PubMed
More than a decade ago our view of gene regulation by glucocorticoids (GC) and other steroid hormones underwent a dramatic change with the discovery of negative crosstalk (transcriptional interference) between the GC receptor (GCR) and transcription factor AP-1 (Jun:Fos). It was initially observed that induction of the collagenase type 1 gene, which is mediated through activation of AP-1 by growth factors and inflammatory cytokines, is repressed by GC. This repression was attributed to mutual negative interactions between AP-1 and GCR. Although the exact molecular mechanism underlying this particular case of transcriptional interference is yet to be determined, it has become clear that this and analogous interactions with other transcription factors (e.g. nuclear factor-kappaB) underlie the anti-inflammatory and immunosuppressive activity of GC. Recent studies conducted at the whole animal level indicate that the interactions between the AP-1 and GC signaling pathways are much more extensive. AP-1-related signaling via the Jun N-terminal kinases can lead to increased levels of circulating GC, which eventually down-modulate AP-1 activity via transcriptional interference. This negative feedback loop is likely to be of great importance for maintenance of homeostasis and regulation of stress responses, including acute and chronic inflammation.
Search for other papers by D Kraus in
Google Scholar
PubMed
Search for other papers by M Fasshauer in
Google Scholar
PubMed
Search for other papers by V Ott in
Google Scholar
PubMed
Search for other papers by B Meier in
Google Scholar
PubMed
Search for other papers by M Jost in
Google Scholar
PubMed
Search for other papers by HH Klein in
Google Scholar
PubMed
Search for other papers by J Klein in
Google Scholar
PubMed
Leptin is an important adipocytokine whose main regulative effects on energy metabolism are exerted via activation of signalling pathways in the central nervous system. Another important regulator of energy homeostasis is insulin. The role of direct autocrine leptin effects on adipose tissue and crosstalk with insulin, in particular in the thermogenically active brown adipose tissue, remains unclear. In the present study, we have investigated leptin secretion and interaction with insulin in highly insulin-responsive immortalised mouse brown adipocytes. Leptin was secreted in a differentiation-dependent manner, and acute leptin treatment of mature adipocytes dose- and time-dependently stimulated phosphorylation of STAT3 and MAP kinase. Interestingly, acute pretreatment of fully differentiated brown adipocytes with leptin (100 nM) significantly diminished insulin-induced glucose uptake by approximately 25%. This inhibitory effect was time-dependent and maximal after 60 min of leptin prestimulation. Furthermore, it correlated with a 35% reduction in insulin-stimulated insulin receptor kinase activity after acute leptin pretreatment. Insulin-induced insulin receptor substrate-1 tyrosine phosphorylation and binding to the regulatory subunit p85 of phosphatidylinositol 3-kinase (PI 3-kinase) were diminished by approximately 60% and 40%, respectively. Taken together, this study has demonstrated strong differentiation-dependent leptin secretion in brown adipocytes and PI 3-kinase-mediated negative autocrine effects of this hormone on insulin action. Direct peripheral leptin-insulin crosstalk may play an important role in the regulation of energy homeostasis.
Search for other papers by Lise Margrethe Sjøgaard-Frich in
Google Scholar
PubMed
Search for other papers by Morten Sølling Henriksen in
Google Scholar
PubMed
Search for other papers by Shi Min Lam in
Google Scholar
PubMed
Search for other papers by Frida Jolande Birkbak in
Google Scholar
PubMed
Search for other papers by Dominika Czaplinska in
Google Scholar
PubMed
Search for other papers by Mette Flinck in
Google Scholar
PubMed
Search for other papers by Stine F. Pedersen in
Google Scholar
PubMed
Non-alcoholic fatty liver disease (NAFLD) is the fastest growing cause of liver-associated death globally. Whole-body knockout (KO) of Na+/H+ exchanger 1 (NHE1, SLC9A1) was previously proposed to protect against high fat diet-induced liver damage, however, mechanistic insight was lacking. The aim of the present work was to address this question in vitro to determine how NHE1 specifically in hepatocytes impacts lipid overload-induced inflammation, fibrosis, and hepatocyte- hepatic stellate cell (HSC) crosstalk. We induced palmitate (PA)-based steatosis in AML12 and HepG2 hepatocytes, manipulated NHE1 activity pharmacologically and by CRISPR-Cas knockout (KO) and -overexpression, and measured intracellular pH (pHi), steatosis-associated inflammatory and fibrotic mediators and cell death. PA treatment increased NHE1 mRNA levels but modestly reduced NHE1 protein expression and hepatocyte pHi. NHE1 KO in hepatocytes did not alter lipid droplet accumulation but reduced inflammatory signaling (p38 MAPK activity), lipotoxicity (4-HNE accumulation) and apoptosis (PARP cleavage). Conditioned medium from PA-treated hepatocytes increased expression of NHE1 and of the fibrosis regulator tissue inhibitor of matrix metalloproteases-2 (TIMP2) in LX-2 HSCs, in a manner abolished by NHE1 KO in hepatocytes. We conclude that NHE1 is regulated in NAFLD in vitro and contributes to the ensuing damage by aggravating hepatocyte injury and stimulating hepatocyte-HSC crosstalk.
Search for other papers by R Ørnsrud in
Google Scholar
PubMed
National Institute of Nutrition and Seafood Research, Department of Animal Physiology, School of Biological Sciences, PO Box 2029 Nordnes, N-5817 Bergen, Norway
Search for other papers by E J Lock in
Google Scholar
PubMed
Search for other papers by C N Glover in
Google Scholar
PubMed
Search for other papers by G Flik in
Google Scholar
PubMed
Vitamins A (VA) and D (VD) are metabolised by vertebrates to bioactive retinoic acid (RA) and calcitriol (CTR). RA and CTR involvement in bone metabolism requires fine-tuned regulation of their synthesis and breakdown. In mammals antagonism of VA and VD is observed, but the mechanism of interaction is unknown. We investigated VA–VD interactions in Atlantic salmon (Salmo salar L.) following i.p. injection of RA and/or CTR. VA metabolites, CTR, calcium (Ca), magnesium (Mg) and phosphorus (P) were determined in plasma. Expression of bone matrix Gla protein (mgp), collagen 1 alpha2 chain (col1a2) and alkaline phosphatase (alp) mRNA was quantified to reflect osteogenesis. Branchial epithelial Ca channel (ecac listed as trpv6 in ZFIN Database) mRNA levels and intestinal Ca and P influx were determined to study Ca/P handling targets of RA and CTR. RA-injection (with or without CTR) decreased plasma CTR-levels three- to sixfold. CTR injection did not affect RA metabolites, but lowered CTR in plasma 3 and 5 days after injection. Lowered plasma CTR correlated with decreased mgp and col1a2 expression in all groups and with decreased alp in CTR-injected fish. RA-treated salmon had enhanced alp expression, irrespective of reduced plasma CTR. Expression of ecac and unidirectional intestinal influx of Ca were stimulated following RA–CTR treatment. Plasma Ca, Mg and P were not affected by any treatment. The results suggest cross-talk of RA with the VD endocrine system in Atlantic salmon. Enhanced Ca flux and osteogenesis (alp transcription) in RA-treated fish and inhibition of mgp expression revealed unprecedented disturbance of Ca physiology in hypervitaminosis A.
Search for other papers by T Takeda in
Google Scholar
PubMed
Search for other papers by H Kurachi in
Google Scholar
PubMed
Search for other papers by T Yamamoto in
Google Scholar
PubMed
Search for other papers by Y Nishio in
Google Scholar
PubMed
Search for other papers by Y Nakatsuji in
Google Scholar
PubMed
Search for other papers by K Morishige in
Google Scholar
PubMed
Search for other papers by A Miyake in
Google Scholar
PubMed
Search for other papers by Y Murata in
Google Scholar
PubMed
Cytokines and steroid hormones use different sets of signal transduction pathways, which seem to be unrelated. Interleukin-6 (IL-6) uses JAK tyrosine kinase and STAT (signal transducer and activator of transcription) transcription factor. Glucocorticoid binds glucocorticoid receptor (GR), which is a member of the steroid receptor superfamily. We have studied the crosstalk between the IL-6-JAK-STAT and glucocorticoid-nuclear receptor pathways. IL-6 and glucocorticoid synergistically activated the IL-6 response element on the rat alpha2-macroglobulin promoter (APRE)-driven luciferase gene. The exogenous expression of GR enhanced the synergism. The exogenous expression of dominant negative STAT3 completely abolished the IL-6 plus glucocorticoid-induced activation of the APRE-luciferase gene. Tyrosine phosphorylation of STAT3 stimulated by IL-6 alone was not different from that by IL-6 plus glucocorticoid. The protein level of STAT3 was also not increased by glucocorticoid stimulation. The time course of STAT3 tyrosine phosphorylation by IL-6 plus glucocorticoid was not different from that by IL-6 alone. The synergism was studied on the two other IL-6 response elements, the junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-1) promoter (IRF-GAS) which could be activated by STAT3. The synergistic activation by glucocorticoid on the IL-6-activated JRE-IL-6 and the IRF-GAS-driven luciferase gene was not detected. Glucocorticoid did not change the mobility of IL-6-induced APRE-binding proteins in a gel shift assay. These results suggest that the synergism was through the GR and STAT3, and the coactivation pathway which was specific for APRE was the target of glucocorticoid.
Search for other papers by Mirja Rotinen in
Google Scholar
PubMed
Search for other papers by Jon Celay in
Google Scholar
PubMed
Search for other papers by Marta M Alonso in
Google Scholar
PubMed
Search for other papers by Aranzazu Arrazola in
Google Scholar
PubMed
Search for other papers by Ignacio Encio in
Google Scholar
PubMed
Search for other papers by Joaquin Villar in
Google Scholar
PubMed
referred as transcriptional crosstalk, involves tethering of the receptor with other transcription factor complexes that contact the DNA. In previous work, we demonstrated that CCAAT boxes located at −5 and −46 contribute dramatically to the basal promoter
Search for other papers by K Alexander H Iwen in
Google Scholar
PubMed
Search for other papers by Oezge Senyaman in
Google Scholar
PubMed
Search for other papers by Arne Schwartz in
Google Scholar
PubMed
Search for other papers by Maren Drenckhan in
Google Scholar
PubMed
Search for other papers by Britta Meier in
Google Scholar
PubMed
Search for other papers by Dirk Hadaschik in
Google Scholar
PubMed
Search for other papers by Johannes Klein in
Google Scholar
PubMed
Our study demonstrates direct multi-level crosstalk of ACTH with key metabolic and endocrine functions of white and brown adipocytes. ACTH induces a transient insulin resistance, a pro-inflammatory adipokine expression profile and a p38 MAPK
Search for other papers by B Gellersen in
Google Scholar
PubMed
Search for other papers by J Brosens in
Google Scholar
PubMed
During the menstrual cycle, the ovarian hormones oestradiol and progesterone control the ordered growth and differentiation of uterine cells. This remodelling process is critical for implantation of the developing embryo, the formation of the placenta, and maintenance of pregnancy. Failure of uterine tIssues to respond appropriately to ovarian hormone signalling results in defective placentation, associated with a spectrum of pregnancy disorders such as recurrent miscarriages and preeclampsia. These obstetrical disorders are a major cause of maternal and perinatal morbidity and mortality. Progesterone exerts its action on target cells, at least in part, through binding to the progesterone receptor (PR), a member of the steroid/thyroid hormone receptor superfamily of ligand-activated transcription factors. The mechanism by which progesterone controls the differentiation of human endometrial stromal cells, a process termed decidualization, in the secretory phase of the menstrual cycle is not well understood. Emerging evidence indicates that locally expressed factors and activation of the cAMP second messenger pathway integrate hormonal inputs and confer cellular specificity to progesterone action through the induction of diverse transcription factors capable of modulating PR function.
Search for other papers by Lingyun Lu in
Google Scholar
PubMed
Search for other papers by Li Tian in
Google Scholar
PubMed
mechanosensitivity of osteocytes. During estrogen deficiency, an increase in osteocyte apoptosis is observed in humans and animals ( Tomkinson et al. 1997 , 1998 ). Following estrogen deficiency, osteocytes trigger bone remodeling via crosstalk with bone
